Joao P De Aquino

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Cross Sectional

Systematic Review

Top Venues

The American journal of drug and alcohol abuse

International review of psychiatry (Abingdon, England)

Addiction biology

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Julio C Nunes, Oluwole O Jegede, Joao P De Aquino
Disentangling the effects of racism-related stress on opioid use disorder and chronic pain outcomes. The American journal of drug and alcohol abuse (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse 50 (1) (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse 50 (1) (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse 50 (1) (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse 50 (1) (2024)
Jeremy Weleff, Julio C Nunes, Gabriel P A Costa, Mehmet Sofuoglu, Robert Ross MacLean, Joao P De Aquino
From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder. British journal of clinical pharmacology (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse 50 (1) (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse 50 (1) (2024)
Gabriel P A Costa, Julio C Nunes, Daniel L Heringer, Akhil Anand, Joao P De Aquino
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American journal of drug and alcohol abuse (2024)
Debora Oliveira, Rodrigo Fontenele, Jeremy Weleff, Mehmet Sofuoglu, Joao P De Aquino
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International review of psychiatry (Abingdon, England) 35 (5-6) (2023)
Debora Oliveira, Rodrigo Fontenele, Jeremy Weleff, Mehmet Sofuoglu, Joao P De Aquino
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International review of psychiatry (Abingdon, England) 35 (5-6) (2023)
Joao P De Aquino, Julia Meyerovich, Catherine Z Xie, Mohini Ranganathan, Peggy Compton, Brian Pittman, Michael Rogan, Mehmet Sofuoglu
Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study. Addiction biology 28 (9) (2023)
Michael Rogan, Julio C Nunes, Catherine Z Xie, Mehmet Sofuoglu, Brian Pittman, Joao P De Aquino
Brief report: The influence of childhood trauma on the effects of delta-9-tetrahydrocannabinol in persons with opioid use disorder. The American journal on addictions (2023)
Debora Oliveira, Rodrigo Fontenele, Jeremy Weleff, Mehmet Sofuoglu, Joao P De Aquino
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International review of psychiatry (Abingdon, England) 35 (5-6) (2023)
Debora Oliveira, Rodrigo Fontenele, Jeremy Weleff, Mehmet Sofuoglu, Joao P De Aquino
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International review of psychiatry (Abingdon, England) 35 (5-6) (2023)
Alexandria Selloni, Gagandeep Bhatia, Mohini Ranganathan, Joao P De Aquino
Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes. Journal of dual diagnosis 18 (2) (2022)
Elizabeth K C Schwartz, Noah R Wolkowicz, Joao P De Aquino, R Ross MacLean, Mehmet Sofuoglu
Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance abuse and rehabilitation 13 (2022)
Joao P De Aquino, Robert Ross MacLean, Ralitza Gueorguieva, Elise E DeVito, Tore Eid, Mehmet Sofuoglu
Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science. Addiction biology 27 (2) (2022)
Joao P De Aquino, Suprit Parida, Mehmet Sofuoglu
Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence. Clinical drug investigation 41 (7) (2021)
Melissa Wright, Joao P De Aquino, Tamara Bystrak
Case report: Increasing the frequency of intramuscular naltrexone administration in a high risk patient with opioid use disorder. Substance abuse 42 (4) (2021)
Joao P De Aquino, Suprit Parida, Mehmet Sofuoglu
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder. Clinical drug investigation 41 (5) (2021)
Joao P De Aquino, Anees Bahji, Deepak C D'Souza
Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again? Cannabis and cannabinoid research (2021)
Joao P De Aquino, José M Flores, Victor J Avila-Quintero, Peggy Compton, Mehmet Sofuoglu
Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta-analysis with implications for drug development. Addiction biology 26 (4) (2020)
Joao P De Aquino, Mehmet Sofuoglu, Elina A Stefanovics, Robert A Rosenheck
Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study. The American journal of drug and alcohol abuse 46 (6) (2020)
Swapnil Gupta, Joao P De Aquino, Deepak C D'Souza, Mohini Ranganathan
Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis. Psychopharmacology 236 (9) (2019)
Joao P De Aquino, Mehmet Sofuoglu, Elina Stefanovics, Robert Rosenheck
Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only. The American journal of drug and alcohol abuse 45 (5) (2019)